Clinical Outcomes from Maximum-Safe Resection of Primary and Metastatic Brain Tumors Using Awake Craniotomy

Brain tumors impose a significant disease burden with the incidence of primary brain cancer of 40.1 per 100,000 of adult population[1]. Surgical resection is a central modality in the management of brain tumors. Accordingly, the extent of surgical resection can significantly impact survival. For instance, in patients with low and high-grade gliomas, the extent of resection has been well correlated with survival in the literature [2 –4]. Moreover, the extent of resection is accepted as one of the most important factors correlating with overall survival, progression-free survival, and malignant transformation in low-grade gliomas[5,6].

Source: Clinical Neurology and Neurosurgery - March 20, 2017 Category: Neurosurgery Authors: Anastasia Groshev, Devang Padalia, Sephalie Patel, Rosemarie Garcia-Getting, Solmaz Sahebjam, Peter A. Forsyth, Frank D. Vrionis, Arnold B. Etame Source Type: research